Status:
UNKNOWN
Evaluation of Blood Biomarkers as an Indicator of Postoperative Cognitive Dysfunction
Lead Sponsor:
SMG-SNU Boramae Medical Center
Conditions:
Postoperative Cognitive Dysfunction
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Postoperative cognitive dysfunction is defined as a cognitive decline arising after surgery. In the present study, the authors evaluate the level of D-Amino Acid Oxidase, D-serine and Serine in blood ...
Eligibility Criteria
Inclusion
- Patients scheduled for elective cardiac surgery
Exclusion
- MMSE \<24
- History of psychological or neurological diseases
- Illiteracy
Key Trial Info
Start Date :
December 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2023
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT04679259
Start Date
December 21 2020
End Date
January 10 2023
Last Update
December 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.